Riskpilot← Back to searchSign inGet full accessAPOTEKFORDEG AS
ASActiveOrg 913877004Hattemakerlia 153, 2019 SkedsmokorsetRetail sale of pharmaceutical products · NACE 4773Est. 20141 employees
Revenue 2023
NOK 7,4M
-64% vs 2022
EBITDA margin
-9.9%
-39% vs 2022
Equity ratio
1.6%
Financial strength
Net profit 2023
NOK -881K
-20% vs 2022
| Revenue | NOK 7,4M | -64% |
| EBITDA | NOK -734K | -39% |
| Net profit | NOK -881K | -20% |
| Total assets | NOK 2,2M | -41% |
| Equity | NOK 36K | +0% |
| Employees | 1 | — |
Legal name
APOTEKFORDEG AS
Org number
913877004
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
10. juli 2014
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Huu erica thien khuong
Company purpose
Eie og drive apotek, herunder konsulenttjenester innenfor apotekerbransjen og lege- og helserelaterte produkter, samt øvrig virksomhet i tilknytning til dette.
Address
Hattemakerlia 153, 2019 Skedsmokorset
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue | 10 556 | 8 381 | 33 782 | 20 480 | 7 439 |
| Staff expenses | −2 891 | −3 134 | −4 799 | −3 599 | −1 937 |
| EBITDA | −54 | −1 995 | −1 842 | −529 | −734 |
| Depreciation & amort. | −55 | −146 | −349 | −204 | −143 |
| EBIT | −108 | −2 142 | −2 191 | −733 | −876 |
| Net financials | −91 | −89 | −13 | −2 | −5 |
| Profit before tax | −200 | −2 231 | −2 204 | −735 | −881 |
| Tax | −44 | 352 | −0 | −0 | −0 |
| Net profit | −156 | −2 583 | −2 204 | −735 | −881 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Total assets | 2 455 | 5 838 | 10 189 | 3 682 | 2 180 |
| Equity | −859 | −125 | −2 329 | 36 | 36 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 3 314 | 5 963 | 12 519 | 3 646 | 2 144 |
| Total debt | 3 314 | 5 963 | 12 519 | 3 646 | 2 144 |
EBITDA margin
-9.9%
This company
15.8%
Market median
-163% vs market
20192023
Equity ratio
1.6%
This company
38.2%
Market median
-96% vs market
20192023
Return on equity
-2458.6%
This company
18.4%
Market median
-13462% vs market
20192023
Net profit margin
-11.8%
This company
8.1%
Market median
-246% vs market
20192023
Asset turnover
3.41×
This company
1.12×
Market median
+204% vs market
20192023
Debt / equity
59.81×
This company
0.62×
Market median
-9547% vs market
20192023
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
SK Deputy Member | Deputy Member | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Former (2) | ||
| Board of Directors | 2021 – 2022 | |
| Board of Directors | 2018 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Pharma Active As
APOTEKFORDEG AS Board members of APOTEKFORDEG AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sven Krohn | Deputy Member | 0 companies |
| Huu Erica Thien Khuong | Board of Directors | 0 companies |
| Ola Magnus Frøysaa | Board of Directors | 0 companies |
| Martin Le | Chairman | 0 companies |
| Atle Martin Haug | Board of Directors | 0 companies |